5 Chemotherapy

@inproceedings{Ermertcan20125C,
  title={5 Chemotherapy},
  author={Aylin T{\"u}rel Ermertcan and Ferdi {\"O}zt{\"u}rk and Kamer G{\"u}nd{\"u}z},
  year={2012}
}
The number of melanoma cases worldwide is increasing faster than any other cancer. Although early detection, appropriate surgery, and adjuvant therapy have improved outcomes, the prognosis of metastatic melanoma remains very poor. Advanced melanoma is still associated with an extremely poor median survival, ranging from 2 to 8 months, with only 5% surviving… CONTINUE READING